Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein
- PMID: 24573404
- DOI: 10.1007/s00795-014-0071-2
Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein
Abstract
Morphological detection of cancer cells in the rabbit VX2 allograft transplantation model is often difficult in a certain region such as serosal cavity where reactive mesothelial cells mimic cancer cells and both cells share common markers such as cytokeratins. Therefore, tagging VX2 cells with a specific and sensitive marker that easily distinguishes them from other cells would be advantageous. Thus, we tried to establish a successively transplantable, enhanced green fluorescent protein (EGFP)-expressing VX2 model. Cancer cells obtained from a conventional VX2-bearing rabbit were cultured in vitro and transfected with an EGFP-encoding vector, and then successively transplanted in Healthy Japanese White rabbits (HJWRs) (n = 8). Besides, conventional VX2 cells were transplanted in other HJWRs (n = 8). Clinicopathological comparison analyses were performed between the two groups. The success rate of transplantation was 100% for both groups. The sensitivity and specificity of EGFP for immunohistochemical detection of VX2 cells were 84.3 and 100%, respectively. No significant differences in cancer cell morphology, tumor size (P = 0.742), Ki-67 labeling index (P = 0.878), or survival rate (P = 0.592) were observed between the two. VX2 cells can be genetically altered, visualized by EGFP, and successively transplanted without significant alteration of morphological and biological properties compared to those of the conventional model.
Similar articles
-
[Establishment of orthotopic lung cancer model expressing enhanced green fluorescent protein].Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):670-5. doi: 10.3779/j.issn.1009-3419.2010.07.03. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673481 Free PMC article. Chinese.
-
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.J Vasc Interv Radiol. 2008 Jun;19(6):931-6. doi: 10.1016/j.jvir.2008.02.019. Epub 2008 Apr 18. J Vasc Interv Radiol. 2008. PMID: 18503910 Free PMC article.
-
Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods.Lab Anim. 2004 Jan;38(1):79-84. doi: 10.1258/00236770460734434. Lab Anim. 2004. PMID: 14979992
-
Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein.Neurosurgery. 1998 Dec;43(6):1437-42; discussion 1442-3. doi: 10.1097/00006123-199812000-00101. Neurosurgery. 1998. PMID: 9848858
-
Development, growth, propagation, and angiographic utilization of the rabbit VX2 model of liver cancer: a pictorial primer and "how to" guide.Diagn Interv Radiol. 2014 Jul-Aug;20(4):335-40. doi: 10.5152/dir.2014.13415. Diagn Interv Radiol. 2014. PMID: 24834491 Free PMC article. Review.
Cited by
-
Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.PLoS One. 2015 Apr 8;10(4):e0123888. doi: 10.1371/journal.pone.0123888. eCollection 2015. PLoS One. 2015. PMID: 25853660 Free PMC article.
-
Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles.Sci Rep. 2016 Apr 22;6:24629. doi: 10.1038/srep24629. Sci Rep. 2016. PMID: 27103308 Free PMC article.
-
Tumor-Targeting Glycol Chitosan Nanoparticles for Image-Guided Surgery of Rabbit Orthotopic VX2 Lung Cancer.Pharmaceutics. 2020 Jul 3;12(7):621. doi: 10.3390/pharmaceutics12070621. Pharmaceutics. 2020. PMID: 32635231 Free PMC article.
-
Trans-Vessel Wall Cell Transplantation, Engraftment, and Tumor Access in the VX2 Rabbit Model.Cell Transplant. 2025 Jan-Dec;34:9636897251313678. doi: 10.1177/09636897251313678. Cell Transplant. 2025. PMID: 39871454 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources